Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Focusing On Promotion Of Pediatric Device Development In 2014

This article was originally published in The Gray Sheet

Executive Summary

One of FDA’s New Year’s resolutions seems to be emphasizing pediatric device development, as seen in a recent final rule on capturing data on pediatric use of devices, as well as a forthcoming draft guidance on pediatric uses of medical devices.

You may also be interested in...

Snapshot: US Pediatric Device Approvals Stay Steady, Despite Overall FDA Surge

The 18% of FY 2015 PMA and HDE device approvals that included pediatric indications was the lowest proportion since FY 2009, even while, overall, 2015 was a record-setting year for novel device approvals.

New Pediatric Chief Medical Officer To Join CDRH

Vasum Peiris, a pediatric cardiologist, is set to join CDRH in August to guide the center's perspectives on devices that could be used in children.

Adult Data To Support Pediatric Use? FDA Drafts Decision Tree To Assess Potential

FDA's device center issued draft guidance on leveraging existing adult – and some pediatric – clinical data for extrapolation to pediatric uses of devices. It provides a decision tree for device sponsors to help determine if available data is suitable to demonstrate safety and effectiveness in a younger population.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts